Oral contraceptive pills market to reach $61.05 billion by 2030 at 15.0% cagr, driven by rising healthcare expenditure.
Read MoreOral clinical nutrition supplement market to reach $18.2 billion by 2030 at 6.6% cagr, driven by growing awareness of preventive healthcare.
Read MoreOral rehydration solution market to reach $6.92 billion by 2030 at 9.4% cagr, driven by increasing incidence of diarrheal diseases.
Read MoreOral proteins and peptides market to reach $4.26 billion by 2030 at 22.2% cagr, driven by growing biopharmaceutical industry.
Read MoreOral mucositis treatment market to reach $3.44 billion by 2030 at 9.9% cagr, driven by increasing use of chemotherapy.
Read MoreOral hypoglycemic agents market to reach $75.62 billion by 2030 at 4.9% cagr, driven by rise in type 2 diabetes prevalence.
Read MoreOral contraceptive pills market to reach $61.05 billion by 2030 at 15.0% cagr, driven by rising healthcare expenditure.
Read MoreOral clinical nutrition supplement market to reach $18.2 billion by 2030 at 6.6% cagr, driven by growing awareness of preventive healthcare.
Read MoreOral clinical nutrition supplement market to reach $18.2 billion by 2030 at 6.6% cagr, driven by growing awareness of preventive healthcare.
Read MorePurine analogues drugs market to reach $27.44 billion by 2030 at 11.0% CAGR, driven by rising prevalence of hematologic malignancies.
Read More